Endometrial cancer (patient information)
For the WikiDoc page for this topic, click here
Editor-in-Chief:
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
What is endometrial cancer?
Endometrial cancer is a cancer that forms in the tissue lining the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a baby grows). It is the most common invasive cancer of the female reproductive system. Most endometrial carcinomas are cancers of the cells that form glands in the endometrium. These are called adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids).
The most common type of endometrial cancer is called endometrioid adenocarcinoma. Other rare types of endometrial carcinomas include squamous cell and undifferentiated. Your doctor may refer to endometrial cancers as "type 1" or "type 2", depending on the potential causes and the nature of the cancer [1]. A cancer would be classified as "type 1" if the cause is exposure to too much estrogen. This type of cancer tends to spread more slowly than a "type 2" cancer.
"Type 2" cancers are less common and their underlying causes remains unknown. They are believed to be caused by factors other than estrogen exposure. This type of cancer is more aggressive than "type 1" and are usually treated more assertively [1].
What are the symptoms of endometrial cancer?
Possible signs of endometrial cancer include unusual vaginal discharge, pain in the pelvis, bleeding or discharge not related to menstruation (periods), difficult or painful urination and pain during sexual intercourse. Since other conditions may cause the same symptoms, you should always consult your doctor if you experience any of these symptoms.
Who is at risk for endometrial cancer?
Endometrial cancer usually occurs in women after menopause, and affects more white women than black women. Black women diagnosed with endometrial cancer are more likely to have more advanced disease at diagnosis, and are more likely to die from endometrial cancer than white women.
Some of the risk factors for endometrial cancer are:
Estrogen Exposure
Estrogen exposure through estrogen-only hormone replacement therapy. A combination estrogen-progestin replacement therapy in post menopausal women, however, has not been shown to increase the risk of endometrial cancer.
Beginning to have menstrual periods at an early age also increases the number of years the body is exposed to estrogen and increases a woman's risk of endometrial cancer. Similarly, women who reach menopause at an older age are exposed to estrogen for a longer time and have an increased risk of endometrial cancer.
Never being pregnant is also a risk factor for endometrial cancer. Because estrogen levels are lower during pregnancy, women who have never been pregnant are exposed to estrogen for a longer time than women who have been pregnant. This increases the risk of endometrial cancer.
Tamoxifen
Tamoxifen is one of a group of drugs called selective estrogen receptor modulators, or SERMs. Tamoxifen is used to prevent breast cancer in women who are at high risk for the disease, but it increases the risk of endometrial cancer. This risk is greater in postmenopausal women.
Another drug in the SERM group, raloxifene, is used to prevent bone weakness in postmenopausal women and has not been shown to increase the risk of endometrial cancer.
Inherited risk
Hereditary nonpolyposis colon cancer (HNPCC) syndrome is an inherited disorder caused by changes in certain genes. Women who have HNPCC syndrome have a much higher risk of developing endometrial cancer than women who do not have HNPCC syndrome.
Polycystic ovary syndrome
Women who have polycystic ovary syndrome (a disorder of the hormones made by the ovaries) have an increased risk of endometrial cancer.
Body fat
Obesity increases the risk of endometrial cancer. This may be because obesity is related to other risk factors such as estrogen levels, polycystic ovary syndrome, lack of physical activity, and a diet that is high in saturated fats.
It is not known if losing weight decreases the risk of endometrial cancer.
How to know you have endometrial cancer?
Because endometrial cancer begins inside the uterus, it does not usually show up in the results of a Pap test. For this reason, a sample of endometrial tissue must be removed and examined under a microscope to look for cancer cells. One of the following procedures may be used:
- Endometrial biopsy: The removal of tissue from the endometrium (inner lining of the uterus) by inserting a thin, flexible tube through the cervix and into the uterus. The tube is used to gently scrape a small amount of tissue from the endometrium and then remove the tissue samples. A pathologist views the tissue under a microscope to look for cancer cells.
- Dilatation and curettage: Surgery to remove samples of tissue or the inner lining of the uterus. The cervix is dilated and a curette (spoon-shaped instrument) is inserted into the uterus to remove tissue. Tissue samples may be taken and checked under a microscope for signs of disease. This procedure is also called a D&C.
When to seek urgent medical care
Treatment options
Diseases with similar symptoms
Where to find medical care for endometrial cancer
Directions to Hospitals Treating endometrial cancer
Prevention of endometrial cancer
What to expect (Outlook/Prognosis)
Sources
Template:SIB Template:WH Template:WS
- ↑ 1.0 1.1 [* http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_is_endometrial_cancer.asp?sitearea=&level= * http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_is_endometrial_cancer.asp?sitearea=&level=] Check
|url=value (help). Missing or empty|title=(help)